Skip to main content

Table 3 Clinical safety outcome measures

From: Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial

 

Nurse-C

LOGIC-C

P value

Patients

773

777

 

Length of ICU stay, median (IQR), days

3 (2–6)

3 (2–6)

0.39

Length of hospital stay, median (IQR), days

12 (8–23)

12 (8–23)

0.18

Mortality in the ICU, n (%)

41 (5.30)

47 (6.05)

0.61

Mortality in the hospital, n (%)

84 (10.81)

72 (9.31)

0.35

Mortality at 90 days, n (%)

89 (11.71)

91 (11.51)

0.93

Incidence of new infections in the ICU, n (%)

117 (15.14)

104 (13.38)

0.35

Ventilator days, median (IQR), days

1 (1–2)

1 (1–3)

0.85

EQ-5D index value at ICU discharge, median (IQR)

0.28 (0.13–0.58)

0.29 (0.13–0.58)

0.59

EQ-5D index value at 90 days, median (IQR)

0.73 (0.56–1)

0.73 (0.56–1)

0.58

EQ-5D VAS score at ICU discharge, median (IQR)

0.60 (0.50–0.70)

0.60 (0.50–0.70)

0.42

EQ-5D VAS score at 90 days, median (IQR)

0.70 (0.60–0.80)

0.70 (0.60–0.80)

0.97

  1. Data are mean (SD), median (IQR) or n (%). LOGIC-C patients randomized to algorithm-guided blood glucose control, Nurse-C patients randomized to blood glucose control by trained nurses, EQ-5D Euroqol-5D, VAS visual analog scale